American depository receipts of European stocks were trading 0.08% higher at 145.25 on the Bank of New York Mellon Europe ADR Index on Friday.
In continental Europe, the gainers were led by cell therapy company TiGenix ( TIG ), which soared 72.5%, followed by geophysical equipment company CGG ( CGG ), which rose 3.8%. Three-dimensional printer maker Voxeljet ( VJET ), and dating company Spark Networks ( LOV ) were up 3.1% and 2.9% respectively.
The decliners in continental Europe were led by Deutsche Bank ( DB ), and semiconductor company Sequans Communications (SQNS), which fell 5.1% and 3.6% respectively. They were followed by biotech firm Zealand Pharma (ZEAL), and financial services firm Credit Suisse (CS), which were down 1.6% and 1%.
In the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP), and Amarin (AMRN), which rose 3.7% and 3.1% respectively. They were followed by Trinity Biotech (TRIB), and medical equipment company Smith & Nephew (SNN), which climbed 2.6% and 2.2%.
The decliners in the UK and Ireland were led by pharmaceutical firm Midatech Pharma (MTP), and biopharmaceutical company Akari Therapeutics (AKTX), which lost 6.5% and 2.3% respectively. They were followed by Barclays Bank (BCS), and biopharmaceutical firm GW Pharmaceuticals (GWPH), which were off 2.4% and 1.46%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.